We are live on
!
Find out more
BL
Bleichroeder LP Portfolio holdings
AUM
$559M
Turnover
17.24%
1-Year Est. Return
83.7%
This Fund
S&P 500
This Quarter
Est. Return
-6.55%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$616M
AUM Growth
-$47.1M
(-7.1%)
Cap. Flow
+$2.74M
Cap. Flow
% of AUM
0.45%
Top 10 Holdings %
Top 10 Hldgs %
61.13%
Holding
110
New
18
Increased
5
Reduced
1
Closed
13
Avg Time Held
0.9
years
Top 10 Avg Time Held
1
year
Top 20 Avg Time Held
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$35.6M |
| 2 |
Cue Health Inc. Common Stock
HLTH
|
+$15.8M |
| 3 |
CORS
Corsair Partnering Corporation
CORS
|
+$12.2M |
| 4 |
TLMD
SOC Telemed, Inc. Class A Common Stock
TLMD
|
+$7.96M |
| 5 |
Sonos
SONO
|
+$5.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Filana Therapeutics
FLNA
|
+$32M |
| 2 |
GRA
W.R. Grace & Co.
GRA
|
+$13.9M |
| 3 |
SHLX
Shell Midstream Partners, L.P.
SHLX
|
+$13.5M |
| 4 |
Optimum Communications Inc
OPTU
|
+$10.2M |
| 5 |
Fate Therapeutics
FATE
|
+$8.68M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.29% |
| 2 | Financials | 14.03% |
| 3 | Industrials | 13.51% |
| 4 | Miscellaneous | 13.22% |
| 5 | Consumer Discretionary | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
INNOVATE Corp
VATE
$84M
| $1.13M | 0.18% |
27,480
| – | – |
2020 Q1
6 quarters
|
|
52
Celcuity
CELC
$2.95B
| $900K | 0.15% |
50,000
| – | – |
2021 Q1
2 quarters
|
|
|
SLGC
53
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $869K | 0.14% |
70,100
| – | – |
2021 Q2
1 quarter
|
|
|
INFI
54
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $855K | 0.14% |
250,000
| – | – |
2019 Q4
7 quarters
|
|
55
BK Technologies
BKTI
$253M
| $848K | 0.14% |
60,000
| – | – |
2021 Q2
1 quarter
|
|
|
PACXW
56
DELISTED
Pioneer Merger Corp. Warrant
PACXW
| $779K | 0.13% |
708,333
| – | – |
2021 Q2
1 quarter
|
|
57
GeneDx Holdings
WGS
$2.13B
| $759K | 0.12% |
+3,030
| New | +$1.04M |
2021 Q3
0 quarters
|
|
58
DELISTED
ARKO Corp Warrant
ARKOW
| $727K | 0.12% |
333,333
| – | – |
2020 Q4
3 quarters
|
|
59
Yext
YEXT
$707M
| $722K | 0.12% |
60,000
| – | – |
2021 Q1
2 quarters
|
|
60
Liberty Global Class A
LBTYA
$2.75B
| $685K | 0.11% |
22,989
| – | – |
2019 Q4
7 quarters
|
|
|
RIBT
61
DELISTED
RiceBran Technologies
RIBT
| $590K | 0.1% |
100,000
| – | – |
2019 Q4
7 quarters
|
|
62
ImmuCell
ICCC
$97.8M
| $567K | 0.09% |
60,607
| – | – |
2021 Q2
1 quarter
|
|
63
Atlanta Braves Holdings Series B
BATRK
$3.21B
| $547K | 0.09% |
20,717
| – | – |
2020 Q2
5 quarters
|
|
64
RTX Corp
RTX
$252B
| $516K | 0.08% |
6,000
| – | – |
2020 Q2
5 quarters
|
|
|
EQRXW
65
DELISTED
EQRx, Inc. Warrant
EQRXW
| $428K | 0.07% |
200,000
| – | – |
2021 Q2
1 quarter
|
|
66
DELISTED
OppFi Inc Warrants
OPFI.WS
| $385K | 0.06% |
+250,000
| New | +$390K |
2021 Q3
0 quarters
|
|
67
L3Harris
LHX
$44.7B
| $352K | 0.06% |
1,600
| – | – |
2019 Q4
7 quarters
|
|
|
CORS.WS
68
DELISTED
Corsair Partnering Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CORS.WS
| $317K | 0.05% |
+416,666
| New | +$326K |
2021 Q3
0 quarters
|
|
69
Carrier Global
CARR
$45B
| $311K | 0.05% |
6,000
| – | – |
2020 Q2
5 quarters
|
|
70
Atlanta Braves Holdings Series A
BATRA
$3.55B
| $279K | 0.05% |
10,356
| – | – |
2019 Q4
7 quarters
|
|
|
ISLEW
71
DELISTED
Isleworth Healthcare Acquisition Corporation Warrant
ISLEW
| $275K | 0.04% |
500,000
| – | – |
2021 Q1
2 quarters
|
|
72
Otis Worldwide
OTIS
$26.6B
| $247K | 0.04% |
3,000
| – | – |
2020 Q2
5 quarters
|
|
73
Liberty Latin America Class C
LILAK
$1.61B
| $217K | 0.04% |
18,174
| – | – |
2020 Q2
5 quarters
|
|
|
LGF.B
74
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $213K | 0.03% |
16,413
| – | – |
2019 Q4
7 quarters
|
|
75
X4 Pharmaceuticals
XFOR
$253M
| $189K | 0.03% |
1,191
| – | – |
2019 Q4
7 quarters
|
|
Similar funds
NFW
SCM
PHC
EPM
BCM
FAM
WDG
OC
Bleichroeder LP's Q3 2021 Portfolio in Review
As of Q3 2021, Bleichroeder LP held 110 positions worth $616M, down 7.1% from $663M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Bleichroeder LP's Q3 2021 filing shows 18 new, 5 increased, 1 reduced and 13 closed positions. Its largest new stake was Cue Health Inc. Common Stock: 1,000,000 shares worth $11.8M. The largest sale was Filana Therapeutics, an estimated $32M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 26% a quarter earlier, followed by Financials and Industrials.
- Bleichroeder LP's largest Q3 2021 buy was Cue Health Inc. Common Stock: 1,000,000 shares worth $11.8M.
- Bleichroeder LP added most to Royalty Pharma in Q3 2021, an estimated $35.6M increase.
- Bleichroeder LP's biggest Q3 2021 reduction was Optimum Communications Inc, cutting an estimated $10.2M.
- Bleichroeder LP fully exited Filana Therapeutics in Q3 2021, selling an estimated $32M.
- Bleichroeder LP's ten largest holdings make up 61% of its $616M portfolio in Q3 2021.
- Bleichroeder LP opened 18 new positions and closed 13 in Q3 2021.
- Bleichroeder LP's portfolio value fell 7.1% quarter-over-quarter to $616M.
Based on Bleichroeder LP's 13F filing for Q3 2021, filed 15 Nov 2021.